LeMaitre Vascular to Attend Key Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq: LMAT) has announced that its management team will be attending three significant investor conferences this September, reflecting the company's dedication to connecting with the investment community.
Upcoming Conferences
LeMaitre Vascular has the following investor conferences lined up:
Morgan Stanley 22nd Annual Global Healthcare Conference
This important event is set for Wednesday, September 4, 2024. David Roberts, the President of LeMaitre, will present at 5:35 PM EST. The conference will take place at the New York Marriott Marquis, offering a great chance for investors to gain insights into the company’s strategic direction and growth plans.
Barrington Research Fall Investment Conference (Virtual)
On Thursday, September 12, 2024, LeMaitre Vascular will take part in the Barrington Research Fall Investment Conference. During this virtual event, George W. LeMaitre, the Chairman & CEO, will conduct a series of one-on-one meetings, providing investors with the opportunity to discuss the company's recent developments and future prospects.
Cantor Fitzgerald 2024 Global Healthcare Conference
This significant event will occur on Thursday, September 19, 2024, at the InterContinental New York Barclay Hotel. David Roberts will again present at this conference, which is scheduled for 8:00 AM EST. This gathering will serve as another platform for LeMaitre to engage with investors and share important updates about their innovative product offerings.
About LeMaitre Vascular
LeMaitre Vascular is committed to providing advanced devices, implants, and services aimed at treating peripheral vascular disease. This condition affects over 200 million people worldwide, emphasizing the vital role of LeMaitre's products in the healthcare sector. The company specializes in developing, manufacturing, and marketing both disposable and implantable vascular devices designed to meet the needs of vascular surgeons who are essential in addressing this widespread health issue.
Commitment to Innovation and Growth
LeMaitre has established a strong reputation for its dedication to innovation in the vascular surgery market. The company consistently invests in research and development to ensure that its product line adapts to the changing needs of healthcare professionals and patients. By participating in major investor conferences, LeMaitre Vascular aims not only to build investor confidence but also to showcase its ongoing projects focused on enhancing patient outcomes.
Frequently Asked Questions
What is LeMaitre Vascular known for?
LeMaitre Vascular is recognized for providing devices and services for the treatment of peripheral vascular disease, which affects millions of people worldwide.
When will LeMaitre Vascular present at the Morgan Stanley conference?
David Roberts, the President of LeMaitre, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024, at 5:35 PM EST.
Which conferences will LeMaitre Vascular attend in September?
LeMaitre Vascular will participate in three conferences: the Morgan Stanley conference, the Barrington Research Fall Investment Conference, and the Cantor Fitzgerald Global Healthcare Conference.
Who is hosting the virtual Barrington Research conference?
George W. LeMaitre, the Chairman & CEO of LeMaitre, will host a series of one-on-one meetings during the virtual Barrington Research Fall Investment Conference on September 12, 2024.
What products does LeMaitre Vascular offer?
LeMaitre Vascular provides a variety of disposable and implantable devices for vascular surgery, specifically designed to effectively treat peripheral vascular disease.